Viyash Scientific Limited has informed the Exchange regarding Outcome of Board Meeting held on April 22, 2026.
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Viyash Scientific Limited's board meeting on April 22, 2026 approved two key appointments. Mr. Amit Jain (Partner and Head of Carlyle India Advisors) and Mr. Abhiroop Jayanthi (Managing Director at Carlyle's Asia Private Equity team) have been appointed as Additional Directors representing the Carlyle group. Both appointments are effective immediately as Non-Executive, Non-Independent Directors, subject to shareholder approval. Additionally, the board revised the ESOP 2026 pool, reducing the stock option pool from 1,34,75,000 to 1,30,98,000 options. Carlyle, a global private equity firm, now gains significant board representation through these appointments.
The entry of two Carlyle-affiliated directors signals increased private equity oversight and potentially strategic focus on value creation. The reduced ESOP pool (by 3,77,000 options) could have minor dilution impact but indicates careful capital management. Shareholders should monitor for potential strategic shifts given Carlyle's involvement in multiple portfolio companies across healthcare and manufacturing sectors.